Prevalence of Hepatitis B Virus in Hemodialysis Patients Infected with Hepatitis C Virus in Mosul District / Iraq

  • Ghusoon Saadoon Hasan Al-Taan Assist. Prof. Nineveh health Directorate, Mosul
  • Mohammed Dawag Khalid Assist. Prof. microbiology, Mosul Blood Bank, Iraq
Keywords: HCV, HBV, hemodialysis

Abstract

Most problematic infection haemodialysis (HD) are at higher risk for acquiring Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections than the general population. Patients and Methods This study was carried out between January 2018 until July 2018, a total of (60) blood samples were collected from hemodialysis patients. The samples tested against anti-HCV, HBsAg anti-HBS and anti-HBC IgM, using ELISA technique and determination HBV-DNA, HCV-RNA viral load by Real time polymerase chain reaction. Results Prevalence HCV RNA was 12(20%) out of 60 patients were RT-PCR positive for HCV RNA with viral load, up to 100.000, Copy/ml and 10(16.69%) out of 60 patients were RT-PCR positive for HBV DNA in both positive and negative HCV RNA patients group with average viral load more than 100.000 copy/ml., 3 Patients out of 12 (25%) HCV RNA, positive patients were also positive for HBV DNA, while 40 (66%) out of 60 patients were anti-HBSAg positive, while the positivity of anti-HBCoIgM was 5 (50%). Conclusion The prevalence of co-infection hepatitis B and C was high in hemodialysis patients in Mosul district/Iraq

References

. H. Puttinge. A: Hepatitis B and C in peritoneal dialysis patients. Nephrol. 22:351,2017

. F. Fabrisi; G. Lunghi and P. Martin. Recent advances in the management of hepatitis C in dialysis population. Int. J. Artif. Organs. 25:503,2011.

. C. Brechot. D. Gozuacik. Y. Murakami et al: Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin cancer Biol. 10: 211, 2015.

. Y. Shiratiori; S. Shiina; P.Y. Zhang, et al: Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in j apan? Cancer. 80: 2060, 20017.

. C. Cauai; M.G. Pojula; I. Bastianoni, et al: Antibody testing and RT-PCR results in hepatitis C virus (HCV) infection HCV RNA detection in PBMC of plasma viremia-negative HCV seropositive persons. Infection 26: 151, 2008.

. W.E. Hitzler and S. Runkel. Routine HCV RNA screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV. Transfusion 41:333, 2011.

. G. Mater; H. Sharara; G. Abdehnour, et al: Genotyping hepatitis C virus isolates from Lebanese hemodialysis patients by reverse transcription-PCR and restriction fragment length polymorphism analysis of 5 noncoding region. J. Clin. mocrobiol. 34:2623, 2006.

. Y.F. Liaw. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 22:1101-1108. 2005.

. A. Asberti; I. Pontisso; I. Fattovich; F. Bencegnu; S. Belussi and Demitri. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J. Hepatol. 22(suppl.1):38-41, 2005.

. H.N. Ohkawak; M. Yuki, and T. Kamada. Long term follow up hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients confected with bothe viruses. J. Med. Virol. 46:258-264, 2005.

. T. Allander; S. Medin; L. Jacovson; M. Persson. Hepatitis C transmission in an hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J. Med. Virol. 43: 415-419. 2004.

. S. Chiaramonte; M. Tagger; A. Ribero; M. Grossi, and G. Lagreca. Prevention of viral hepatitis in dialysis unit: isolatin and technical management of dialysis. Nephron 61:287-289. 2002.

. P. Druwe; A. Michielsen; M. Ramon and E. Debroe. Hepatitis C and nephrology. Nephrol. Dial. Transplant. 9:230-237. 2014.

. C. Pau; M. Cuervo; M. Ardila and Teran. Hepatitis C transmission through dialysis maehines. ASAIO (AM.SO.Artip. Itesn. Orgon) J. 40:M889M891. 2004.

. P. Dentico; R. Volpe; A. Buongiorno, and M. Manno. Hepatitis C virus in hemodialysis patients. Nephron 61: 307-308. 20017.

. C. Huang; S. Ho; S. Yang; L. Lee, and A. Tan. Hepatitis C marker in hemodialysis patients. J. Clin. Microbiol. 31: 1764-1769. 2003.

. Y. Irie; H. Hayashi. T. Yokozeki; T. Kashima and Okudak. Hepatitis C infection un related to blood transfusion in hemodialysis patients. J. Hepatol. 20: 557-559. 2016.

. G. Muller; A. Zabaleta; C. Arminio and N. Capriles. Risk factors for dialysis-associated hepatitis C in Venezuela. Kedney Int. 41:1055-1058. 2014.

. M. Sampietro; S. Badalamenti; N. Salvadori and C. Ponticelli. High prevalence of a rare hepatitis C virus in patients treated in same hemodialysis unit: evidence for nosocomial transmition of HCV. Kidney, Int. 46: 504-551. 2011.

. L. Stuyver; A. Claeys; W. vanArnhem; G. Maertens and M. Depaepe. Hepatitis C virus in hemodialysis unit: molecular evidence for nosocomial trans mission. Kidney Int. 49: 889-895. 2017.

. K. Okuda; S. Hoyashi; S. Kobaqoshi and Y. Irie. Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J. Hepatol. 21: 28-31. 2009.

. R. Johnson; R. Wilson; W. Yamabe; M. Alpers and C. Wener. Renal manifestation of hepatitis C virus infection. Kidney Into 46: 1255-1263. 1994.

. V. Mioli; L. Balestra; P. Bibiano, and et al. Epidemiology of viral hepatitis in dialysis center: national survey. Nephron 61:278-283. 2002.

. R. Fukuda; N. Ishimura; M. Niigaki et al. Serological silent hepatitis B virus confection in patients with hepatitis C virus associated chronic liver disease: clinical and virological significance. J. Med. Virol; 58:201-7, 1999.

. Caccio; T. Policino; G. Squadrito; G. Cerenzia; M.E. Orlando; G. Raimondo. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl. J. Med.; 341:22-6, 2009.

. V. Goral; H. Ozkul; S. Tekes; D. Sit; A.K. Kadiroslu. Prevalence of occult HBV infection in hemodialysis patients with chronic HCV. World J. Gastroenterol; 12(21): 3420-4. 2006.

. M. Arababadi; G. Hassanshahi and H. Yousefi. HBV-DNA in Hemodialysis patients infected by HCV. Saudi J. Kidney Dis. Trans plant; 20(3): 398-401. 2009.

Published
2020-01-08
Section
Articles